Abattis Bioceuticals Corp (OTCQX: ATTBF) (CSE: ATT) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment ...